Despite the recent downward trend in DOJ healthcare industry settlements, the first quarter of 2024 saw many noteworthy False Claims Act (FCA) and civil healthcare fraud settlements related to alleged kickbacks, medically unnecessary services and equipment, pharmaceutical issues and Controlled Substances Act violations.
Continue Reading False Claims Act Settlements to Know from Q1 2024The United States Intervenes in its First False Claims Act Cybersecurity Case
The United States notified the U.S. District Court for the Northern District of Georgia that it plans to intervene in a False Claims Act case filed against Georgia Tech Research Corporation (Georgia Tech) by its Associate Director of Cybersecurity and former Principal Information Security Engineer (the relators).
Continue Reading The United States Intervenes in its First False Claims Act Cybersecurity CaseRegister Now | Healthcare Fraud & Abuse Annual Review Webinar Replay
Bass, Berry & Sims released its 12th Annual Healthcare Fraud & Abuse Review on February 26, 2024. As a companion to the Review, we hosted a complimentary webinar which provided an overview and discussion of key focus areas covered in the Review. We are pleased to offer an encore presentation of this webinar on April 25, 2024.
Continue Reading Register Now | Healthcare Fraud & Abuse Annual Review Webinar ReplayRegister Now | HHS-OIG Year in Review Webinar Replay
In 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) offered the industry new and updated guidance tools and a late flurry of advisory opinions. Join us for a webinar in which we will provide a high-level overview of 2023’s most significant and helpful guidance documents.
Continue Reading Register Now | HHS-OIG Year in Review Webinar ReplaySecond Circuit Clarifies Anti-Kickback Statute’s Scienter Requirement
On March 12, the U.S. Court of Appeals for the Second Circuit issued an important decision that sheds light on the test for determining scienter under the federal Anti-Kickback Statute (AKS).
Continue Reading Second Circuit Clarifies Anti-Kickback Statute’s Scienter RequirementDrug Diversion within Long-Term Care Industry
In a recent McKnight’s Long-Term Care News article, we discussed heighted scrutiny within the long-term care industry related to drug diversion and compliance with the Controlled Substances Act (CSA). Healthcare organizations, and not just diverting employees, are more often being held accountable for diversion of controlled substances.
Continue Reading Drug Diversion within Long-Term Care IndustryDownload Now – 12th Annual Healthcare Fraud & Abuse Review
Bass, Berry & Sims is pleased to announce the release of the 12th annual Healthcare Fraud & Abuse Review examining important healthcare fraud developments in 2023.
Continue Reading Download Now – 12th Annual Healthcare Fraud & Abuse ReviewDOJ Releases Annual Civil Fraud Recovery Statistics and Results…A Look Behind the Numbers
On February 22, the Department of Justice (DOJ) released its annual report of civil fraud recoveries for FY2023, along with a press release highlighting DOJ’s civil enforcement efforts.
Continue Reading DOJ Releases Annual Civil Fraud Recovery Statistics and Results…A Look Behind the NumbersDistrict Court Finds that $487 Million False Claims Act Judgment Violates Eighth Amendment
On February 8, the U.S. District Court for the District of Minnesota ruled that a $487 million False Claims Act (FCA) damages award entered last year against Precision Lens and its co-founder violated the Eighth Amendment’s prohibition on excessive fines and ordered the judgment reduced by more than half.
Continue Reading District Court Finds that $487 Million False Claims Act Judgment Violates Eighth AmendmentRegister Now | HHS-OIG Year in Review Webinar
In 2023, the U.S. Department of Health and Human Services (HHS) Office of Inspector General (OIG) offered the industry new and updated guidance tools and a late flurry of advisory opinions. Join us on February 27 from 12:00 p.m. – 1:00 p.m. CT for a webinar in which we will provide a high-level overview of 2023’s most significant and helpful guidance documents.
Continue Reading Register Now | HHS-OIG Year in Review Webinar